{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:40:36Z","timestamp":1792482036532,"version":"4.5.0"},"posted":{"date-parts":[[2026,7,5]]},"group-title":"In Review","reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:00:00Z","timestamp":1783209600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,6,26]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  Endocytosis regulates receptor trafficking and signaling, yet its role in colorectal cancer (CRC) remains unclear. We analyzed transcriptomic data from 15,025 CRC tumors to evaluate gene expression in clathrin-mediated endocytosis (CME) and the endosomal sorting complexes required for transport (ESCRT) pathway. Pathway-level signatures were compared across consensus molecular subtypes (CMS) and examined in relation to oncogenic signaling programs, while individual endocytosis-related genes were evaluated for associations with clinical outcomes in an independent randomized trial cohort. Expression of CME and ESCRT pathways varied by CMS, with the highest expression in CMS4 and the lowest in CMS3. Endocytosis signatures correlated with multiple oncogenic signaling pathways, including MAPK, TGF-\u03b2, WNT, PI3K, NOTCH, and angiogenesis, suggesting broad links between endocytic activity and tumor biology. In the randomized phase III CALGB\/SWOG 80405 trial, low expression of\n                  <italic>AP2M1<\/italic>\n                  \u2014a core adaptor in the CME complex\u2014was significantly associated with longer overall survival and progression-free survival in patients treated with anti-EGFR agents, but not in those receiving anti-VEGF agents. These findings suggest that endocytic trafficking may be associated with oncogenic signaling and differential therapeutic benefit in patients with metastatic CRC. The endocytosis pathway reflects biologically relevant heterogeneity in CRC and may help guide therapeutic stratification.\n                <\/p>","DOI":"10.21203\/rs.3.rs-10164107\/v1","type":"posted-content","created":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T13:00:09Z","timestamp":1783256409000},"source":"Crossref","is-referenced-by-count":0,"title":["Activation of the endocytosis pathway stratifies subtypes and therapeutic sensitivity in colorectal cancer"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1886-7070","authenticated-orcid":false,"given":"Hiroyuki","family":"Arai","sequence":"first","affiliation":[{"name":"Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8494-8031","authenticated-orcid":false,"given":"Andrew","family":"Elliott","sequence":"additional","affiliation":[{"name":"Clinical & Translational Research, Medical Affairs, Caris Life Sciences, Phoenix, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7883-0798","authenticated-orcid":false,"given":"Yan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Population and Public Health Sciences, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Farrell","sequence":"additional","affiliation":[{"name":"Clinical & Translational Research, Medical Affairs, Caris Life Sciences, Phoenix, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7961-8943","authenticated-orcid":false,"given":"Joshua","family":"Millstein","sequence":"additional","affiliation":[{"name":"Department of Population and Public Health Sciences, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1267-8735","authenticated-orcid":false,"given":"Fang-Shu","family":"Ou","sequence":"additional","affiliation":[{"name":"Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Innocenti","sequence":"additional","affiliation":[{"name":"UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6931-0359","authenticated-orcid":false,"given":"Jingyuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Battaglin","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2480-4057","authenticated-orcid":false,"given":"Priya","family":"Jayachandran","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Algaze","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Soni","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0308-8223","authenticated-orcid":false,"given":"Richard M.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"West Virginia University Cancer Institute, Morgantown, WV, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron James","family":"Scott","sequence":"additional","affiliation":[{"name":"Division of hematology\/oncology, University of Arizona Cancer Center, Tucson, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy J.","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Solid Tumor Oncology, GI Medical Oncology, Levine Cancer Institute, Charlotte, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1607-1386","authenticated-orcid":false,"given":"Emil","family":"Lou","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Weinberg","sequence":"additional","affiliation":[{"name":"Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Marshall","sequence":"additional","affiliation":[{"name":"Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2798-7568","authenticated-orcid":false,"given":"Sanjay","family":"Goel","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Rutgers Cancer Institute, New Brunswick, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Xiu","sequence":"additional","affiliation":[{"name":"Clinical & Translational Research, Medical Affairs, Caris Life Sciences, Phoenix, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Michael","family":"Korn","sequence":"additional","affiliation":[{"name":"Clinical & Translational Research, Medical Affairs, Caris Life Sciences, Phoenix, AZ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan P.","family":"Venook","sequence":"additional","affiliation":[{"name":"University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2178-9568","authenticated-orcid":false,"given":"Heinz-Josef","family":"Lenz","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrc2521","article-title":"Derailed endocytosis: an emerging feature of cancer","volume":"8","author":"Mosesson Y","year":"2008","unstructured":"Mosesson Y, Mills GB, Yarden Y. Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer 8, 835\u2013850 (2008).","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrm2748","article-title":"Endocytosis and signalling: intertwining molecular networks","volume":"10","author":"Sorkin A","year":"2009","unstructured":"Sorkin A, von Zastrow M. Endocytosis and signalling: intertwining molecular networks. Nat Rev Mol Cell Biol 10, 609\u2013622 (2009).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nrm3244","article-title":"Endocytic control of growth factor signalling: multivesicular bodies as signalling organelles","volume":"13","author":"Dobrowolski R","year":"2011","unstructured":"Dobrowolski R, De Robertis EM. Endocytic control of growth factor signalling: multivesicular bodies as signalling organelles. Nat Rev Mol Cell Biol 13, 53\u201360 (2011).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0092-8674(00)81701-8","article-title":"SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor","volume":"95","author":"Tsukazaki T","year":"1998","unstructured":"Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 95, 779\u2013791 (1998).","journal-title":"Cell"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cell.2010.11.034","article-title":"Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes","volume":"143","author":"Taelman VF,","year":"2010","unstructured":"Taelman VF, et al. Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 143, 1136\u20131148 (2010).","journal-title":"Cell"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1158\/0008-5472.CAN-16-3403","article-title":"Behind the Scenes: Endo\/Exocytosis in the Acquisition of Metastatic Traits","volume":"77","author":"Lanzetti L","year":"2017","unstructured":"Lanzetti L, Di Fiore PP. Behind the Scenes: Endo\/Exocytosis in the Acquisition of Metastatic Traits. Cancer Res 77, 1813\u20131817 (2017).","journal-title":"Cancer Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1083\/jcb.200807186","article-title":"A clathrin-dependent pathway leads to KRas signaling on late endosomes en route to lysosomes","volume":"184","author":"Lu A,","year":"2009","unstructured":"Lu A, et al. A clathrin-dependent pathway leads to KRas signaling on late endosomes en route to lysosomes. J Cell Biol 184, 863\u2013879 (2009).","journal-title":"J Cell Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrm.2017.132","article-title":"Mechanisms of clathrin-mediated endocytosis","volume":"19","author":"Kaksonen M","year":"2018","unstructured":"Kaksonen M, Roux A. Mechanisms of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol 19, 313\u2013326 (2018).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm3151","article-title":"Molecular mechanism and physiological functions of clathrin-mediated endocytosis","volume":"12","author":"McMahon HT","year":"2011","unstructured":"McMahon HT, Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol 12, 517\u2013533 (2011).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"R116-120","DOI":"10.1016\/j.cub.2012.01.028","article-title":"The ESCRT machinery","volume":"22","author":"Schmidt O","year":"2012","unstructured":"Schmidt O, Teis D. The ESCRT machinery. Curr Biol 22, R116-120 (2012).","journal-title":"Curr Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tibs.2016.08.016","article-title":"Cellular Functions and Molecular Mechanisms of the ESCRT Membrane-Scission Machinery","volume":"42","author":"Christ L","year":"2017","unstructured":"Christ L, Raiborg C, Wenzel EM, Campsteijn C, Stenmark H. Cellular Functions and Molecular Mechanisms of the ESCRT Membrane-Scission Machinery. Trends Biochem Sci 42, 42\u201356 (2017).","journal-title":"Trends Biochem Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41580-019-0177-4","article-title":"The many functions of ESCRTs","volume":"21","author":"Vietri M","year":"2020","unstructured":"Vietri M, Radulovic M, Stenmark H. The many functions of ESCRTs. Nat Rev Mol Cell Biol 21, 25\u201342 (2020).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cell.2019.03.030","article-title":"Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities","volume":"177","author":"Vasaikar S,","year":"2019","unstructured":"Vasaikar S, et al. Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities. Cell 177, 1035\u20131049 e1019 (2019).","journal-title":"Cell"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney J,","year":"2015","unstructured":"Guinney J, et al. The consensus molecular subtypes of colorectal cancer. Nat Med 21, 1350\u20131356 (2015).","journal-title":"Nat Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1001\/jama.2017.7105","article-title":"Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial","volume":"317","author":"Venook AP,","year":"2017","unstructured":"Venook AP, et al. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial. JAMA 317, 2392\u20132401 (2017).","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1471-2105-15-224","article-title":"MAP-RSeq: Mayo Analysis Pipeline for RNA sequencing","volume":"15","author":"Kalari KR,","year":"2014","unstructured":"Kalari KR, et al. MAP-RSeq: Mayo Analysis Pipeline for RNA sequencing. BMC Bioinformatics 15, 224 (2014).","journal-title":"BMC Bioinformatics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41698-018-0051-4","article-title":"A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types","volume":"2","author":"Wagle MC,","year":"2018","unstructured":"Wagle MC, et al. A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types. NPJ Precis Oncol 2, 7 (2018).","journal-title":"NPJ Precis Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature23669","article-title":"Identification of CMTM6 and CMTM4 as PD-L1 protein regulators","volume":"549","author":"Mezzadra R,","year":"2017","unstructured":"Mezzadra R, et al. Identification of CMTM6 and CMTM4 as PD-L1 protein regulators. Nature 549, 106\u2013110 (2017).","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr ML","year":"2017","unstructured":"Burr ML, et al. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature 549, 101\u2013105 (2017).","journal-title":"Nature"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41589-018-0161-x","article-title":"HIP1R targets PD-L1 to lysosomal degradation to alter T cell-mediated cytotoxicity","volume":"15","author":"Wang H,","year":"2019","unstructured":"Wang H, et al. HIP1R targets PD-L1 to lysosomal degradation to alter T cell-mediated cytotoxicity. Nat Chem Biol 15, 42\u201350 (2019).","journal-title":"Nat Chem Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1291179","DOI":"10.3389\/fcell.2023.1291179","article-title":"Epigenomic reprogramming of therapy-resistant circulating tumor cells in colon cancer","volume":"11","author":"Bao-Caamano A,","year":"2023","unstructured":"Bao-Caamano A, et al. Epigenomic reprogramming of therapy-resistant circulating tumor cells in colon cancer. Front Cell Dev Biol 11, 1291179 (2023).","journal-title":"Front Cell Dev Biol"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.5028","article-title":"Targeted disruption of GAK stagnates autophagic flux by disturbing lysosomal dynamics","volume":"48","author":"Miyazaki M,","year":"2021","unstructured":"Miyazaki M, et al. Targeted disruption of GAK stagnates autophagic flux by disturbing lysosomal dynamics. Int J Mol Med 48, (2021).","journal-title":"Int J Mol Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00432-021-03561-2","article-title":"High expression of tumor susceptibility gene 101 (TSG101) is associated with more aggressive behavior in colorectal carcinoma","volume":"147","author":"Gheytanchi E,","year":"2021","unstructured":"Gheytanchi E, et al. High expression of tumor susceptibility gene 101 (TSG101) is associated with more aggressive behavior in colorectal carcinoma. J Cancer Res Clin Oncol 147, 1631\u20131646 (2021).","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s41419-018-1217-2","article-title":"HCRP-1 regulates EGFR-AKT-BIM-mediated anoikis resistance and serves as a prognostic marker in human colon cancer","volume":"9","author":"Chen F,","year":"2018","unstructured":"Chen F, et al. HCRP-1 regulates EGFR-AKT-BIM-mediated anoikis resistance and serves as a prognostic marker in human colon cancer. Cell Death Dis 9, 1176 (2018).","journal-title":"Cell Death Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/modpathol.2016.72","article-title":"Exosomes in colorectal carcinoma formation: ALIX under the magnifying glass","volume":"29","author":"Valcz G,","year":"2016","unstructured":"Valcz G, et al. Exosomes in colorectal carcinoma formation: ALIX under the magnifying glass. Mod Pathol 29, 928\u2013938 (2016).","journal-title":"Mod Pathol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e10812","DOI":"10.15252\/emmm.201910812","article-title":"Synthetic lethality between VPS4A and VPS4B triggers an inflammatory response in colorectal cancer","volume":"12","author":"Szymanska E,","year":"2020","unstructured":"Szymanska E, et al. Synthetic lethality between VPS4A and VPS4B triggers an inflammatory response in colorectal cancer. EMBO Mol Med 12, e10812 (2020).","journal-title":"EMBO Mol Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.celrep.2019.05.017","article-title":"Molecularly Distinct Clathrin-Coated Pits Differentially Impact EGFR Fate and Signaling","volume":"27","author":"Pascolutti R,","year":"2019","unstructured":"Pascolutti R, et al. Molecularly Distinct Clathrin-Coated Pits Differentially Impact EGFR Fate and Signaling. Cell Rep 27, 3049\u20133061 e3046 (2019).","journal-title":"Cell Rep"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.molcel.2019.09.030","article-title":"Mechanisms Controlling PD-L1 Expression in Cancer","volume":"76","author":"Cha JH","year":"2019","unstructured":"Cha JH, Chan LC, Li CW, Hsu JL, Hung MC. Mechanisms Controlling PD-L1 Expression in Cancer. Mol Cell 76, 359\u2013370 (2019).","journal-title":"Mol Cell"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10164107\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10164107\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:07:13Z","timestamp":1792480033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-10164107\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,5]]},"references-count":28,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-10164107\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41388-026-04019-w","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2026,7,5]]},"subtype":"preprint"}}